Men's Health Company Achieves Major FDA-approved Treatment

Petros Pharmaceuticals Achieves Notable Progress with Phase 2 Study for STENDRA (avanafil) Rx-to-OTC Switch.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant breakthrough for erectile dysfunction treatment, Petros Pharmaceuticals Inc. ($PTPI), a leading men's health therapeutics company, has announced successful completion of the initial cohort of …